To prevent infection, pathogenesis, and severe diseases, antibodies produced by the COVID-19 vaccine target distinct regions of the viral spike protein (IMAGE)

Osaka Metropolitan University

To prevent infection, pathogenesis, and severe diseases, antibodies produced by the COVID-19 vaccine target distinct regions of the viral spike protein

Caption

Antibodies that primarily target the N-terminal domain (NTD) have less ability to protect against delta strains than antibodies that primarily target the receptor-binding domain (RBD).

Credit

Osaka Metropolitan University

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.